As part of its ongoing mission to expand and optimize its clinical research infrastructure and provide patients access to the most advanced cancer treatment and prevention strategies available, UVA Cancer Center welcomes two world-class clinicians and researchers to grow its bone marrow transplant program.▸ Read More
- Case Studies
- Centers of Excellence
- Clinical Trial
- CME Opportunity
- Heart & Vascular
- Home Healthcare
- New Faculty Profiles
- New Services
- News Briefs
- Practice Tips & Tools
Pulmonology 4/13/2016UVA Is Improving the Odds for Lung Transplant Patients
Ex Vivo Lung Perfusion extends the period of time lungs can remain viable outside of the body, giving lung recipients access to lungs in locations beyond the region in which they are listed.
Pulmonology 1/11/2016Differentiating Among Interstitial Lung Diseases
The UVA Interstitial Lung Disease Program is one of just 40 centers in the U.S. designated as a Pulmonary Fibrosis Foundation Care Network site, which speaks to the level of expertise and quality of care provided, as well as the progress being made at UVA in advancing treatment for these complex lung disorders.